dc.date.accessioned |
2021-06-04T08:06:07Z |
|
dc.date.available |
2021-06-04T08:06:07Z |
|
dc.date.issued |
2021 |
|
dc.identifier.issn |
0393-6384 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12619/95633 |
|
dc.description |
Bu yayının lisans anlaşması koşulları tam metin açık erişimine izin vermemektedir. |
|
dc.description.abstract |
Introduction: The outbreak of the new coronavirus disease 2019 (COVID-19) has become the most significant global health threat in the World. We do not have well-established guidelines for cancer patients. We aimed to clarify chemotherapy's oncologic outcomes in patients with active cancer and asymptomatic COVDI 19 disease. Material and methods: This study is single-center research and designed prospectively. Only patients who were receiving intravenous systemic chemotherapy were selected and tested for COVID19 Results: During the peak period of the COVID-19 pandemic for Turkey, we started the study and analyzed 198 patients. Eighty (40%) patients were male, and 118 (60%) patients were female. Following the analysis, there was no nasal and pharyngeal swab specimen PCR positive patient, but 7 (3.5%) of 199 patients had blood antibody test positive and received their regular chemotehrapies. No patient died during the 90 days follow up. Conclusions: Even though we cannot generalize, emergent chemotherapies can administered to the COVID-19 patients if the patient did not have any symptoms for COVID-19. |
|
dc.language |
English |
|
dc.language |
İngilizce |
|
dc.language.iso |
eng |
|
dc.publisher |
CARBONE EDITORE |
|
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject |
MORTALITY |
|
dc.title |
COVID-19 PREVALENCE AND ONCOLOGIC OUTCOMES OF ASYMPTOMATIC PATIENTS WITH ACTIVE CANCER WHO RECEIVED CHEMOTHERAPY |
|
dc.type |
Article |
|
dc.contributor.authorID |
Bilir, Cemil/0000-0002-1372-4791; Altindis, Mustafa/0000-0003-0411-9669 |
|
dc.contributor.authorID |
Bilir, Cemil/0000-0002-1372-4791 |
|
dc.contributor.authorID |
Altindis, Mustafa/0000-0003-0411-9669 |
|
dc.identifier.volume |
37 |
|
dc.identifier.startpage |
667 |
|
dc.identifier.endpage |
671 |
|
dc.relation.journal |
ACTA MEDICA MEDITERRANEA |
|
dc.identifier.issue |
1 |
|
dc.identifier.wos |
WOS:000621776000103 |
|
dc.identifier.doi |
10.19193/0393-6384_2021_1_103 |
|
dc.identifier.eissn |
2283-9720 |
|
dc.contributor.author |
Bilir, Cemil |
|
dc.contributor.author |
Cakir, Emre |
|
dc.contributor.author |
Gulbagci, Burcu |
|
dc.contributor.author |
Altindis, Mustafa |
|
dc.contributor.author |
Toptan, Hande |
|
dc.contributor.author |
Guclu, Ertugrul |
|
dc.contributor.author |
Demirci, Ayse |
|
dc.contributor.author |
Bayoglu, Ibrahim Vedat |
|
dc.contributor.author |
Hacibekiroglu, Ilhan |
|
dc.contributor.author |
Varim, Ceyhun |
|
dc.relation.publicationcategory |
Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı |
|